Renal handling of uric acid under cyclosporin A treatment
- PMID: 3152994
- DOI: 10.1007/BF00870373
Renal handling of uric acid under cyclosporin A treatment
Abstract
The renal handling of uric acid during cyclosporin A (CyA) treatment was investigated by clearance studies using 24-h urine collections in 28 paediatric renal transplant recipients (CyA group), and the results were compared with those of 19 renal transplanted children treated with azathioprine and prednisolone (AZA group), 35 children with chronic renal failure (CRF) and 10 children with normal renal function (N group). Serum uric acid levels were significantly higher in the CyA group (567 +/- 156 mumol/l) compared with the AZA group (378 +/- 98), the CRF group (415 +/- 119) and the N group (290 +/- 68). Mean uric acid clearances in each group measured 3.9 +/- 2.8 ml/min per 1.73 m2 (CyA), 5.6 +/- 3.4 (AZA), 4.0 +/- 2.2 (CRF) and 8.4 +/- 3.7 (N). Calculation of the net tubular uric acid reabsorption per millilitre glomerular filtration rate revealed a significantly increased value of 0.53 +/- 0.15 mumol/ml in the CyA group (P less than 0.01) compared with 0.34 +/- 0.08, 0.29 +/- 0.15 and 0.27 +/- 0.07 mumol/l for the AZA, CRF and N groups respectively. We therefore conclude that CyA treatment is associated with an increased net tubular reabsorption of uric acid, which may lead to hyperuricaemia.
Similar articles
-
Low-dose cyclosporin A therapy in cadaver renal transplantation in children.Transpl Int. 1989 Dec;2(4):203-8. doi: 10.1007/BF02414535. Transpl Int. 1989. PMID: 2697210 Clinical Trial.
-
Reversibility of cyclosporin nephrotoxicity after three months' treatment.Lancet. 1985 Jan 19;1(8421):128-30. doi: 10.1016/s0140-6736(85)91902-6. Lancet. 1985. PMID: 2857212 Clinical Trial.
-
Cyclosporine inhibits renal uric acid transport in renal transplants not in children treated for nephrotic syndrome.Ren Fail. 1990;12(3):193-8. doi: 10.3109/08860229009065563. Ren Fail. 1990. PMID: 2287772
-
Hyperuricaemia in cyclosporin-treated patients: GFR-related effect.Nephrol Dial Transplant. 1996 Jan;11(1):153-8. Nephrol Dial Transplant. 1996. PMID: 8649625
-
The incidence of gout in renal transplant recipients.Am J Kidney Dis. 1987 Nov;10(5):369-72. doi: 10.1016/s0272-6386(87)80103-8. Am J Kidney Dis. 1987. PMID: 3314490
Cited by
-
Hyperuricemia beyond 1 year after kidney transplantation in pediatric patients: Prevalence and risk factors.Indian J Nephrol. 2012 Jul;22(4):280-4. doi: 10.4103/0971-4065.101248. Indian J Nephrol. 2012. PMID: 23162272 Free PMC article.
-
Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome.Clin J Am Soc Nephrol. 2009 Sep;4(9):1409-16. doi: 10.2215/CJN.01520209. Epub 2009 Jul 23. Clin J Am Soc Nephrol. 2009. PMID: 19628686 Free PMC article.
-
The pathophysiology of Sandimmune (cyclosporine) in man and animals.Pediatr Nephrol. 1990 Sep;4(5):554-74. doi: 10.1007/BF00869843. Pediatr Nephrol. 1990. PMID: 2242327 Review.
-
Natural history and etiology of hyperuricemia following pediatric renal transplantation.Pediatr Nephrol. 1995 Feb;9(1):57-60. doi: 10.1007/BF00858973. Pediatr Nephrol. 1995. PMID: 7742224 Clinical Trial.
-
Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis.Klin Wochenschr. 1988 Nov 15;66(22):1126-37. doi: 10.1007/BF01727848. Klin Wochenschr. 1988. PMID: 3236762
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources